- Open Access
Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins
© Liu et al; licensee BioMed Central Ltd. 2008
- Received: 17 June 2008
- Accepted: 18 July 2008
- Published: 18 July 2008
Studies on Rift Valley Fever Virus (RVFV) infection process and morphogenesis have been hampered due to the biosafety conditions required to handle this virus, making alternative systems such as recombinant virus-like particles, that may facilitate understanding of these processes are highly desirable. In this report we present the expression and characterization of RVFV structural proteins N, Gn and Gc and demonstrate the efficient generation of RVFV virus-like particles (VLPs) using a baculovirus expression system.
A recombinant baculovirus, expressing nucleocapsid (N) protein of RVFV at high level under the control of the polyhedrin promoter was generated. Gel filtration analysis indicated that expressed N protein could form complex multimers. Further, N protein complex when visualized by electron microscopy (EM) exhibited particulate, nucleocapsid like-particles (NLPs). Subsequently, a single recombinant virus was generated that expressed the RVFV glycoproteins (Gn/Gc) together with the N protein using a dual baculovirus vector. Both the Gn and Gc glycoproteins were detected not only in the cytoplasm but also on the cell surface of infected cells. Moreover, expression of the Gn/Gc in insect cells was able to induce cell-cell fusion after a low pH shift indicating the retention of their functional characteristics. In addition, assembly of these three structural proteins into VLPs was identified by purification of cells' supernatant through potassium tartrate-glycerol gradient centrifugation followed by EM analysis. The purified particles exhibited enveloped structures that were similar to the structures of the wild-type RVFV virion particle. In parallel, a second recombinant virus was constructed that expressed only Gc protein together with N protein. This dual recombinant virus also generated VLPs with clear spiky structures, but appeared to be more pleomorphic than the VLPs with both glycoproteins, suggesting that Gc and probably also Gn interacts with N protein complex independent of each other.
Our results suggest that baculovirus expression system has enormous potential to produce large amount of VLPs that may be used both for fundamental and applied research of RVFV.
- Insect Cell
- Recombinant Baculovirus
- Fusion Activity
- Rift Valley Fever Virus
- Baculovirus Expression System
RVFV is a member of the Phlebovirus genus within the Bunyaviridae family. It is endemic in North Africa and the Arabia peninsula, infecting both livestock and humans [1, 2]. Infection of humans provokes a wide range of symptoms, from fever to fatal encephalitis, retinitis and hepatitis associated with haemorrhages [3, 4] while in livestock and wild ruminants it causes teratogeny and abortion in pregnant animals and produces high rate of mortality in young animals. Like other members of the genus, RVFV is vector-borne, mainly transmitted by mosquitoes of Aedes species, although many others species are also capable of virus replication and transmission and thus increasing the possibilities of outbreaks in Sub-Saharan regions [5, 6].
RVFV is an enveloped virus with a diameter of 90 to 110 nm and a core element of 80 to 85 nm [7, 8]. The viral genome consists of single-stranded, tripartite RNA, among which the large (L) and medium (M) segments are negative polarity, and the small (S) segment is ambisense polarity [9–11]. The L segment codes for the RNA-dependent RNA polymerase, which is packed together with the genomic RNA segments within the virus particles . The S segment codes for two proteins, the structural nucleoprotein (N) in the negative sense and the small non-structural protein (NSs) in the positive sense . The N protein is the nucleocapsid protein and is closely associated with the genome RNA in the virion particles, and the NSs protein inhibits host gene transcription in the infected cells thereby blocking interferon production [12, 13]. The M segment encodes two structural glycoproteins Gn (encoded by amino-terminal sequences) and Gc (encoded by carboxy-terminal sequences), and two non-structural proteins the 78 kDa and the 14 kDa NSm protein [11, 14, 15] that are produced in a complex strategy of translation initiation and polyprotein processing. The mRNA transcribed from the M segment has five in-frame initiation codons upstream of the Gn and Gc sequence [14–16]. The 78-KDa protein is translated from the first AUG and includes the entire coding sequence of Gn whereas NSm protein starts from the second AUG to the beginning of Gc. Neither the 78-KDa nor the 14 KDa proteins seems to be essential for virus replication in cell culture [16, 17], and their function is still unclear.
The structural glycoproteins Gn and Gc are expressed as a polyprotein precursor that is processed by cellular proteases during its maturation and result in a heterodimeric complex . It has been shown that oligomerization of viral glycoproteins occurs most probably in the endoplasmic reticulum (ER) and is critical for their transit to the Golgi apparatus . As for other members of the Bunyaviridae family, RVFV glycoproteins are localized to the Golgi apparatus [18, 19] where the remaining structural proteins and the genome are recruited prior to budding. Although the receptor utilized by RVFV is still unknown, Gn and Gc are sufficient for virus entry during infection and a low pH activation after endocytosis of the virion is essential for this process [20, 21].
Studies on RVFV infection process and morphogenesis have been hampered due to the requirement of high biosafety conditions to handle this virus, thus alternative systems that may facilitate understanding of these processes are highly desirable. To this end a number of recombinant protein expression systems including bacteria, vaccinia virus, baculovirus systems and more recently alphavirus-based vector have been used to generate RVFV structural proteins [22–25]. However, to date production of multi-component RVFV VLPs has not been achieved. Assembly of VLPs of many viruses by recombinant expression systems had been highly successful both for understanding the fundamental aspects of virus life cycle as well as for its immunogenic properties (see reviews [26, 27]). In this report we present the expression and characterization of RVFV structural proteins N, Gn and Gc and demonstrate the efficient generation of VLPs in insect cells using a single recombinant baculovirus.
Expression of N protein produces complex structures
Recent studies have demonstrated that the basic oligomeric status of N protein in purified ribonucleoprotein (RNP) from RVFV infected cells is a dimer, however it exhibited multimeric organization when RNPs were cross-linked with glutaraldehyde . To investigate if recombinant N synthesized in insect cells is capable of oligomerisation, the supernatant of infected insect cells were clarified, ultracentrifuged through a sucrose cushion and protein products were analyzed by gel filtration column chromatography. The products obtained from the gel filtration are shown in Fig. 1B. A distinct protein peak was detected in the exclusion region (the column exclusion size limit was 1300 kD) suggesting that the N protein was able to form complex structures. To determine the position of N protein complex a series of protein control molecular markers were included and their relative position is indicated in the figure. When aliquots of gel filtration fractions were analyzed by SDS-PAGE (Fig. 1C), a band of the expected size for N was detected, suggesting that N was the major component in those fractions. To confirm further that the eluted band was indeed the N protein of RVFV, and had the same mobility with the N protein band of the cell lysate an aliquot was analyzed by Western blot using anti-N antibody (Fig. 1D, lane 3).
To determine if N protein containing fractions could form any particulate complex structure, fractions containing N protein were clarified by ultracentrifugation and aliquots were visualized by electron microscopy (EM). Distinct particulate structures could be detected under EM (Fig. 1E). The size of these structures ranged from 56 to 78 nm, suggesting that N could indeed form complex multimeric structures.
Expression of three structural proteins by a single recombinant virus
RVFV virus particle are enveloped, and the two structural glycoproteins Gn and Gc are inserted in the membrane that surrounds the RNP. To investigate if RVFV glycoproteins can be assembled together with N protein in baculovirus expression system, a dual protein expression vector was designed. Previous works using vaccinia and baculovirus systems have shown that the expression of Gn/Gc from the fourth AUG of M segment produce high level and correct processing of both proteins [24, 28]. Indeed of the five AUG initiation codons present in the upstream sequence of Gn only the fourth AUG is in optimal translation context sequence. Therefore for the baculovirus construct, the open reading frame of M segment from the fourth AUG was used. The Gn/Gc and N sequences were inserted into the baculovirus transfer vector under the control of two separate polyhedrin promoters. The recombinant baculovirus was generated as described in Methods.
Gn and Gc are targeted to the plasma membrane of insect cells
It has been reported previously that when RVFV Gn and Gc are expressed individually, Gn is targeted to the Golgi while Gc is retained in the ER [18, 19]. However, Filone et al. have recently shown that the overexpression of Gn and Gc by alphavirus replicon vectors resulted in the localization of these proteins in the cell surface . Therefore it was of interest if this effect could be observed in insect cells by recombinant baculovirus expressing these glycoproteins. To visualize the expression of Gn/Gc complex on the cell surface, insect cells were infected with the recombinant baculovirus expressing Gn, Gc and N proteins and 30 hours post-infected cells were fixed and processed for immunofluorescence. Since these cells were not permeabilized only proteins expressed in the surface of cells should be detected. When specific antibody against Gn was used as a primary antibody and FITC-conjugated as secondary antibody, a strong signal around the surface of infected cells was easily visible (Fig. 2C, upper panel). Similar result was obtained when a specific antibody against Gc and TRITC-conjugated secondary antibody were used (Fig. 2D, upper right panel). As a control, cells were infected with a recombinant baculovirus expressing β-Galactosidase protein and processed similarly. Although low level of background was detected when the FITC-conjugated secondary antibody was used, no background was observed for the TRITC-conjugated antibody (Fig. 2C and 2D, lower panels).
Thus, the expression of RVFV Gn and Gc proteins in insect cells resulted in detection of both proteins on the surface of the non-permeabilized infected cells. The presence of Gn and Gc on the surface of infected insect cell suggests that the both proteins were correctly folded and properly processed.
Surface expression of RVFV Gn/Gc can induce membrane fusion
To further characterize the pH dependence of the fusion activity of the complex Gn/Gc a range of pH were tested. The fusogenic ability was assessed as the average number of syncytia in at least 20 fields of visual microscopy at 100× magnification, in three independent experiments. As shown in Fig. 3B a significant number of syncytia were counted when cells expressing Gn/Gc were treated at low pH (between pH 4.5 to 5.5) and as expected the number decrease at high pH (pH 6.0 to 7.0). As expected, no evidence of fusion was observed in control cells expressing BTV VP2. These results demonstrated that Gn/Gc expressed in insect cells by recombinant baculovirus has a pH dependent fusion activity. Similar result were observed with alphavirus expressed Gn/Gc .
These results suggest that Gn/Gc expressed in the baculovirus expression system is fully functional and share similar characteristics with that of native RVFV infection and other recombinant systems.
Co-expression of RVFV N and Gn/Gc or GC protein assemble into virus-like particle
In order to analyze if this concentrated sample indeed contained VLPs, an aliquot of the purified and concentrated fraction was examined by EM. Particulate structures with a spiky outer layer ranging from 90–120 nm were found in this fraction (Fig. 4B). These structures resemble the structure of RVFV. Some particles preserved nearly perfect surface subunits, which were presumably formed by Gn and Gc heterodimeric complex similar to that of virion particles  (Fig. 4B). The clarity of these surface spikes could easily be counted around 26 to 37 as shown in Fig. 4B (note the three particles in the lower panels). These results suggest that the structures purified from the supernatant of cells expressing RVFV structural proteins N and Gn/Gc are indeed VLPs.
Further, to determine the localization of VLPs in the cytosol and to confirm that VLPs were matured in the vacuoles, insect cells infected with the recombinant baculovirus expressing the three RVFV proteins were harvested, fixed and processed for ultra-section analysis. The results obtained from EM analysis showed that particulate structures, similar to RVFV virion particles, were released into vacuoles (Fig. 4C, indicated by black arrows). There were also a large number of inclusion bodies accumulated in the cytoplasm (Fig. 4D, indicated by arrow). Similar virion particles and inclusion bodies have also been reported to be present in RVFV-infected hepatocytes .
The results suggest that Gc was expressed and together with N protein produced spiky virus-like structures. Therefore, it can be hypothesized that Gc (and probably Gn) interact with RNP complex independent of each other during virus infection.
RVFV is an important pathogen which infects both humans and livestock with a mortality rate of 1–3% among humans. Studies on the assembly of RVFV are particularly difficult due to the level of biosafety facilities necessary to undertake these studies. For this reason the development of alternative models with lower biosafety requirements is crucial for this virus.
In this work we present evidence of VLP assembly when insect cells were infected with a recombinant baculovirus expressing RVFV structural proteins N, Gn and Gc. In addition, we have also shown evidence of VLP formation when only N and Gc were expressed, in the absence of Gn. Moreover, when RVFV N was expressed alone in absence of both glycoproteins, distinct particulate structures were identified that could be isolated from infected cells.
The N nucleoprotein of Bunyaviridae members is the major virion component. It is closely associated with viral genomic RNA along with the L polymerase to form helical ribonucleoprotein (RNP) structures. These RNPs can adopt a circular conformation due to the complementary sequences present at the non-coding regions of the viral genome [31–34]. It is interesting to note that when the N protein of Hantaan virus, another member of the Bunyaviridae family, was expressed either by baculovirus or vaccinia virus expression systems, linear structures were formed similar to RNPs . To our knowledge there is no previous data for expression of the N protein of RVFV in an insect cell-baculovirus expression system. Our results have shown that complex circular structures could be purified from recombinant baculovirus infected cells expressing RVFV N protein. These structures were about 56 to 78 nm in size and there were no visible surface projections. It has been reported that RVFV N protein forms dimers in the ribonucleoproteins purified from RVFV infected cells . However, our data indicate that N protein could form multimeric complex and assembled into a particulate structure in the absence of genomic RNA.
The fact that large amount of RVFV N protein could be purified from the media of infected cells suggests that this protein might have a pathway for its release independent to the viral proteins Gn, Gc or the viral genome. In some groups of viruses nucleoproteins can be released outside of host cells when expressed in the absence of other viral proteins [35–38].
The assembly of bunyaviruses takes place mainly intracellularly by budding into the Golgi vesicles. Both glycoproteins Gn and Gc are localized in the Golgi apparatus when expressed as a polyprotein. However, it has been shown that when expressed individually Gc was localized to the ER in absence of Gn [39, 40], which suggests that Gc reaches the Golgi apparatus by interacting with Gn. There is no consensus motif for Golgi localization of Gn and Gc among bunyaviruses. In the case of RVFV the Gn contains a Golgi retention motif and the Gc contains a ER retention signal. When these proteins were expressed individually, they localized in Golgi and ER apparatus, respectively . Interestingly a fraction of Gn was also detected on the cell surface when the protein was expressed in the absence of Gc . Additionally, it has been reported that RVFV can also bud from the cell membrane  indicating that a fraction of a Gn/Gc complex may be present on the surface of infected cells. Recent work has shown that the overexpression of RVFV glycoproteins using alphavirus vectors produced the expression of Gn and Gc on the cell surface . Therefore, detection of baculovirus expressed Gn and Gc on the surface of infected cells in our study was not entirely unexpected.
Expression of RVFV glycoproteins using the baculovirus expression system has been reported before [24, 28] but functional analysis of these proteins was not completed. In order to analyze the expression, correct processing, folding, and interaction of Gn/Gc complex the fusion capacity of Gn/Gc proteins was assessed using a cell to cell fusion assay. In bunyaviruses, Gn/Gc mediates virus entry by fusion of viral and cellular membranes after endocytosis of the virons at low pH [21, 29]. In our study we showed that exposure of the infected cells to low pH was necessary to induce fusion activity of the recombinant proteins. A large number of syncytia were observed when cells expressing Gn/Gc were exposed to a low pH for only 2 minutes. The receptor(s) and the cellular factors that are utilized by RVFV during natural infection are still unknown, but equivalents appeared to be present at the surface of the insect cell used for Gn/Gc expression. These results suggest that both proteins were correctly expressed and processed in the insect cells.
Further, the simultaneous expression of N and Gn/Gc in insect cells also readily assembled into VLPs, emphasizing that the expressed proteins were correctly processed. These VLPs could be purified from the supernatant. Under EM, structures with spherical shape and projections protruding from the surface, resembling RVFV virus, were detected. The coexpression of N and Gn/Gc produced reasonably uniform particles with spikes that were clearly visible.
Interestingly, when RVFV N and Gc proteins were coexpressed, VLPs with pleomorphic shapes and sizes could also be purified from the supernatant of infected cells. It is important to note that our constructs for expressing Gc included a frame-shifted Gn ORF. As a result, a peptide of 47 amino acids corresponding to the N-terminal part of Gn would be expressed. The effect of this fragment on the assembly of N/Gc VLPs, if any, was not investigated. In the vaccinia virus expression system approximately half of the total RVFV Gc protein was produced independently from the five AUGs located at the pre-glycoprotein coding sequence , most probably due to an internal translation initiation. If this is the case, a fragment of Gn may be expressed. Whether a potentially truncated Gn was expressed in our system which may be functional and supportive to the transport of N/Gc VLPs remains unanswered. Thus our data suggests that even if the truncated Gn might have aided in the production and release of some sort of VLPs, the full-length Gn protein together with Gc, is required for the stable morphology and the spike structures.
In mammalian cells RVFV virus particles are released to the vacuoles of Golgi or endoplasmic reticular sources [7, 41]. Our experiment showed that in the baculovirus expression system, the mature VLPs in the vacuoles of insect cells and a large amount of viral inclusion body were also detected in the cytoplasm. It needs further investigation to understand the property and function of these structures in the viral particle formation.
This is the first example of Bunyaviridae VLPs that are efficiently generated in a baculovirus expression system. Previously, by expression of the M and S segment of Hantaan virus, VLPs were assembled in mammalian cells using recombinant vaccinia virus but were not produced in insect cells with similar recombinant baculovirus . The success of efficiently producing RVFV VLPs in insect cells and successfully recovering the VLPs from the culture media, together with the finding that the Gn and Gc proteins produced in recombinant Vaccinia virus and recombinant baculovirus efficiently trigger immune reactions in mice to lethal RVFV infections [22, 24] indicate that the baculovirus-insect cells is a powerful system to produce large amount of RVFV VLPs for the purpose of vaccine production.
We have expressed three structural proteins of RVFV either singly or together; the nucleocapsid N protein and the two structural glycoproteins Gn and Gc. The N protein when expressed singly under the control of the polyhedrin promoter was very high level and could be isolated from the supernatant of infected cells. The purified protein formed multimeric complexes and exhibited as a nucleocapsid-like particle (NLPs) structures. When the three proteins were expressed simultaneously by a single recombinant virus, both the Gn and Gc glycoproteins were detected not only in the cytoplasm but also in the cell surface of the infected cells. Expression of these proteins induced cell-cell fusion upon low pH shift. Moreover, VLPs were detected in the cytoplasm and, when purified from supernatant of infected cells, these particles exhibited enveloped structures similar to that of the wild-type RVFV virion particles. Interestingly, Gc and N also formed VLPs with clear spiky structures when they were expressed in the absence of Gn protein. These particles appeared to be more pleomorphic than the VLPs with both glycoproteins, suggesting that both Gn and Gc are needed to generate uniform, stable particles. However, it is clear that Gc and probably also Gn interacts with N protein complex independent of each other. Our results indicate that baculovirus expression system has enormous potential to produce large amount of VLPs that may be used both for fundamental research such as virus entry and morphology study, as well as for vaccination purposes.
Cells and virus
The cell lines used in this study were Spodoptera frugiperda Sf9 and Sf21. Sf9 cells were grown in Sf900II serum-free media (Gibco) and Sf21 cells were growth in TC100 media (Sigma) supplemented with 10% fetal calf serum (FCS). Both cell lines were incubated at 28°C. Recombinant baculoviruses based on Autographa californica nuclear polyhedrosis virus (AcNPV) were propagated in Sf21 cells.
Source of viral material and antibodies
Purified RVFV viral RNAs were obtained from Dr. Mark Outlaw, National Collection for Pathogenic Viruses, Porton Down, UK. Monoclonal antibodies, against Gn, Gc and N were generously provided by Dr. Connie Schmaljohn (USAMRIID, Frederick, MD). Monoclonal antibodies anti-N, anti-G1, anti-G2, and polyclonal antibody against RVFV virus strain Zinga were provided by Dr. Michele Bouloy (Institut Pasteur, Paris, France). For cell surface expression assay anti mouse-fluorescein isothiocyanate (FITC)-conjugated and anti mouse-tetramethylrhodamine isothiocyanate (TRITC)-conjugated (Sigma) were used. For fusion assay purified anti-baculovirus envelope gp64 protein (e-Bioscience) was used.
The full-length cDNA of the M segment was obtained by reverse PCR using primers 5'-ACGCGTGTCGACACACAAAGATGGTGCATTAAATGTATG-3' and 5'-GAATTCAGATCTACACAAAGACCGGTGCAACTTC-3', and the cDNA of the N protein coding region was generated by reverse PCR using primers 5'-GTCGACGGATCCCCATGGACAACTATCAAGAGCTTCG-3' and 5'-CTCGAGGAATTCAGATCTTAGGCTGCTGTCTTGTAAGCC-3'. The PCR products were cloned into pM83B  and translation context sequences were added by site-directed mutagenesis before the 4th ATG for the Gn/Gc with primer 5'-GGTCTTCCATGGCGGCCGCCCGGGCTG CATCCAAC-3', or before the start codon of the N protein with primer 5'-GTTGTCCATGGCGGCCGCGTCGACCTGCAG-3'. The fragment containing the N ORF and the context was transferred to the transfer vector pRN16 (generated in Roy's lab, unpublished), derived from CL29 , to produce pRN-N. The fragment including the context and the sequence from the fourth ATG to the end of the Gn was inserted to pRN16 to obtain pRN-4th Gn/Gc. The EcoRV-KpnI fragment of pRN-4th Gn/Gc, which contained the polyhedron promoter and the Gn/Gc genome, was inserted to pRN-N to construct pRN-Ns-4th Gn/Gc. A sequence containing an extra base, C, between the 625th and 626th nucleotides of the M segment was inserted into pRN16 to create pRN-Ns-Gnmut/Gc. This mutation introduces a frame shift after translating 47 amino acid of the Gn and stopped after 8 additional amino acids.
Expression in insect cells
Bacmid BAc10:KO1629  DNA was cotransfected with transfer vectors pRN-N, pRN-N-4thGnmut/Gc or pRN-N-4thGn/Gc into Sf21, to obtain recombinant baculoviruses containing respective expression cassettes. A modified protocol was used to combine the cotransfection and plaque assay, and individual plaques were picked after six days. The recombinant baculoviruses were amplified in Sf21 cells and virus stocks were stored at 4°C. Insect cells were infected with the recombinant virus stocks to examine the recombinant protein expression and VLP production.
SDS-polyacrylamide gel electrophoresis and Western blotting
Protein expression was analyzed by SDS-polyacrylamide (7.5 to 10%) gels (PAGE) . Proteins were either stained with Commassie brilliant blue or transferred to a cellulose nitrate membrane (Schleicher & Schuell) using a semi-dry transfer cell (Bio-Rad) for Western blotting . Monoclonal antibodies against RVFV Gn, Gc or N proteins diluted 1:1000 in 2% (w/v) milk-phosphate buffer (PBS) were incubated with membranes for one hour. The secondary antibody (anti-mouse IgG conjugated with alkaline phosphatase) (Sigma) was diluted 1:10000. The membranes were finally developed with BCIP-NBT substrate (Sigma).
N and VLP purification
Sf9 cells were infected with the recombinant baculovirus expressing RVFV N protein at MOI of 3 and 4 days post-infection, the media were clarified by centrifugation for 20 minutes at 9000 rpm at 4°C. The supernatant was precipitated through a 20% (w/v) sucrose cushion in TNE buffer (100 mM Tris-HCl, pH 7.4; 100 mM NaCl; 1 mM EDTA) by altracentrifugation (SW28 for 2 hours at 25,000 rpm). The pellet was resuspended in 20 mM Tris-HCl pH 8.0 and further purified by size exclusion liquid chromatography (SEC) gel filtration using Superdex 200 HR 10/30 (Amersham Biosciences). Fractions of 0.5 ml were collected and kept at 4°C for further analysis.
For VLP purification Sf9 cells were infected with a recombinant baculovirus expressing N and either Gn/Gc polyprotein or Gc for 4 days. Infected cell medium was harvested and after clarification and ultracentrifugation as before, the pellet was resuspended in 20 mM Tris-HCl pH 8.0 and layered on top of step sucrose gradient 20%, 30% and 40% (w/v)  and centrifuged for 4 hours at 190000 × g at 4°C. Alternatively, the sample was purified through a potassium tartrate-glycerol gradient  by centrifugation for 18 hours in SW 28 rotor at 28,000 rpm. Visual band or fractions of 0.5 ml were collected and analyzed for the presence of RVFV proteins. Positive fractions were diluted with TNE buffer and ultracentrifuged through a sucrose cushion. The pellet was resuspended in TNE buffer and stored at 4°C.
Cell surface expression of Gn and Gc
Sf9 cells were grown in monolayer on glass coverslips and infected with recombinant baculovirus expressing RVFV Gn, Gc and N. 30 hours post-infected cells were washed and incubated for 20 min in 4% (w/v) paraformaldehyde in PBS, followed by an hour in 1% (w/v) BSA in PBS buffer. As primary antibodies anti-G1 or anti-G2 monoclonals were used at 1:100 dilutions. Subsequently, cells were incubated with secondary antibodies fluorescein isothiocyanate (FITC)-conjugated (Sigma) or tetramethylrhodamine isothiocyanate (TRITC)-conjugated (Sigma) prior to examining the samples by Nikon Eclipse TS100 or Zeiss Axiovert 200 M laser-scanning microscope.
Sf9 cells were grown in monolayers and then infected with the recombinant baculovirus expressing Gn, Gc and N at MOI of 0.5. At 24 hours post-infection an antibody against baculovirus gp64 was added to the media. After 2 hours the media was replaced with low pH media and incubated further for 2 minutes and then replaced with normal pH medium. Incubation was continued approximately 2 hours until syncytia were visible. As a control, Sf9 cells were infected at MOI of 0.5 with a baculovirus expressing Bluetongue virus (BTV) VP2 protein. Syncytia were counted by visual microscopy at 100× magnification.
Negative staining and Electron microscopy (EM)
A purified sample was spun in a micro-centrifuge at full speed for 10 minutes. An aliquot of the supernatant was placed onto a carbon-coated grid, dried with the edge of a piece of filter paper and stained with a drop of 3% phosphotungstic acid (PTA) pH 6.8 . All samples were examined using a Jeo 1200 EX transmission microscope.
Cultured Sf9 cells were collected by spinning down at 1000 rpm for 2 minutes and washed once with serum-free fresh culture medium. The final cell pellet was fixed with 2% glutaraldehyde in serum-free fresh culture medium and embedded in agar, and cut into smaller cubes. The cubes were embedded in epoxy resin and ultra sections were cut, mounted onto formva-coated grid, and stained with 2% uracil acetate, pH 5.5 .
We are grateful to Dr. Mark Outlaw for provide the purified RVFV RNAs, to Dr. Connie Schmaljohn and Ms. Cindy A. Rossi, Dr. Michele Bouloy and Dr. Agnès Billecocq for kindly providing monoclonal or polyclonal antibodies, to Miss Maria Mccrossan for help in cell-section and EM work.
- Gad AM, Hassan MM, el Said S, Moussa MI, Wood OL: Rift Valley fever virus transmission by different Egyptian mosquito species. Trans R Soc Trop Med Hyg. 1987, 81 (4): 694-698. 10.1016/0035-9203(87)90460-3.View ArticlePubMedGoogle Scholar
- Meadors GF, Gibbs PH, Peters CJ: Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials. Vaccine. 1986, 4 (3): 179-184. 10.1016/0264-410X(86)90007-1.View ArticlePubMedGoogle Scholar
- Balkhy HH, Memish ZA: Rift Valley fever: an uninvited zoonosis in the Arabian peninsula. Int J Antimicrob Agents. 2003, 21 (2): 153-157. 10.1016/S0924-8579(02)00295-9.View ArticlePubMedGoogle Scholar
- Peters CJ, Liu CT, Anderson GW, Morrill JC, Jahrling PB: Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev Infect Dis. 1989, 11 Suppl 4: S743-9.View ArticlePubMedGoogle Scholar
- Centers for Disease Control and Prevention: Outbreak of Rift Valley fever - Saudi Arabia, August - October 2000. Morb. Mortal. Wkly. Rep. 2000, 905-908.Google Scholar
- Centers for Disease Control and Prevention: Outbreak of Rift Valley fever - Yemen, August - October 2000. Morb. Mortal. Wkly. Rep. 2000, 1065-1066.Google Scholar
- Ellis DS, Simpson DI, Stamford S, Abdel Wahab KS: Rift Valley fever virus: some ultrastructural observations on material from the outbreak in Egypt 1977. J Gen Virol. 1979, 42 (2): 329-337. 10.1099/0022-1317-42-2-329.View ArticlePubMedGoogle Scholar
- Ellis DS, Shirodaria PV, Fleming E, Simpson DI: Morphology and development of Rift Valley fever virus in Vero cell cultures. J Med Virol. 1988, 24 (2): 161-174. 10.1002/jmv.1890240205.View ArticlePubMedGoogle Scholar
- Muller R, Poch O, Delarue M, Bishop DH, Bouloy M: Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J Gen Virol. 1994, 75 ( Pt 6): 1345-1352. 10.1099/0022-1317-75-6-1345.View ArticleGoogle Scholar
- Giorgi C, Accardi L, Nicoletti L, Gro MC, Takehara K, Hilditch C, Morikawa S, Bishop DH: Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology. 1991, 180 (2): 738-753. 10.1016/0042-6822(91)90087-R.View ArticlePubMedGoogle Scholar
- Collett MS: Messenger RNA of the M segment RNA of Rift Valley fever virus. Virology. 1986, 151 (1): 151-156. 10.1016/0042-6822(86)90114-5.View ArticlePubMedGoogle Scholar
- Le May N, Gauliard N, Billecocq A, Bouloy M: The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization. J Virol. 2005, 79 (18): 11974-11980. 10.1128/JVI.79.18.11974-11980.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O: NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol. 2004, 78 (18): 9798-9806. 10.1128/JVI.78.18.9798-9806.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Kakach LT, Suzich JA, Collett MS: Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation. Virology. 1989, 170 (2): 505-510. 10.1016/0042-6822(89)90442-X.View ArticlePubMedGoogle Scholar
- Suzich JA, Collett MS: Rift Valley fever virus M segment: cell-free transcription and translation of virus-complementary RNA. Virology. 1988, 164 (2): 478-486. 10.1016/0042-6822(88)90562-4.View ArticlePubMedGoogle Scholar
- Gerrard SR, Nichol ST: Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins. Virology. 2007, 357 (2): 124-133. 10.1016/j.virol.2006.08.002.View ArticlePubMedGoogle Scholar
- Won S, Ikegami T, Peters CJ, Makino S: NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J Virol. 2006, 80 (16): 8274-8278. 10.1128/JVI.00476-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Wasmoen TL, Kakach LT, Collett MS: Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins. Virology. 1988, 166 (1): 275-280. 10.1016/0042-6822(88)90174-2.View ArticlePubMedGoogle Scholar
- Gerrard SR, Nichol ST: Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein. J Virol. 2002, 76 (23): 12200-12210. 10.1128/JVI.76.23.12200-12210.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Filone CM, Heise M, Doms RW, Bertolotti-Ciarlet A: Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors. Virology. 2006, 356 (1-2): 155-164. 10.1016/j.virol.2006.07.035.View ArticlePubMedGoogle Scholar
- Garry CE, Garry RF: Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes). Theor Biol Med Model. 2004, 1: 10-10.1186/1742-4682-1-10.PubMed CentralView ArticlePubMedGoogle Scholar
- Collett MS, Keegan K, Hu SL, Sridhar P, Purchio AF, Ennis WH, Dalrymple JM: Protective subunit immunogens to Rift Valley Fever virus from bacteria and recombinant vaccinia virus. The biology of negative strand viruses. Edited by: Mahy B, Kolakofsky D. 1987, New York , Elsevier Science Publishing Inc., 321-329.Google Scholar
- Keegan K, Collett MS: Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus. J Virol. 1986, 58 (2): 263-270.PubMed CentralPubMedGoogle Scholar
- Schmaljohn CS, Parker MD, Ennis WH, Dalrymple JM, Collett MS, Suzich JA, Schmaljohn AL: Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. Virology. 1989, 170 (1): 184-192. 10.1016/0042-6822(89)90365-6.View ArticlePubMedGoogle Scholar
- Suzich JA, Kakach LT, Collett MS: Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment. J Virol. 1990, 64 (4): 1549-1555.PubMed CentralPubMedGoogle Scholar
- Noad R, Roy P: Virus-like particles as immunogens. Trends Microbiol. 2003, 11 (9): 438-444. 10.1016/S0966-842X(03)00208-7.View ArticlePubMedGoogle Scholar
- Roy P, Noad R: Virus-Like Particles as a Vaccine Delivery System: Myths and Facts. Pharmaceutical Biotechnology. Edited by: Guzman C, Feuerstein G. 2008, Austin/New York , Landes Bioscience/Springer ScienceGoogle Scholar
- Kakach LT, Wasmoen TL, Collett MS: Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression. J Virol. 1988, 62 (3): 826-833.PubMed CentralPubMedGoogle Scholar
- Ronka H, Hilden P, Von Bonsdorff CH, Kuismanen E: Homodimeric association of the spike glycoproteins G1 and G2 of Uukuniemi virus. Virology. 1995, 211 (1): 241-250. 10.1006/viro.1995.1397.View ArticlePubMedGoogle Scholar
- Hassan SH, Roy P: Expression and functional characterization of bluetongue virus VP2 protein: Role in cell entry. J Virol. 1999, 73 (12): 9832-9842.PubMed CentralPubMedGoogle Scholar
- Hewlett MJ, Pettersson RF, Baltimore D: Circular forms of Uukuniemi virion RNA: an electron microscopic study. J Virol. 1977, 21 (3): 1085-1093.PubMed CentralPubMedGoogle Scholar
- Pettersson RF, von Bonsdorff CH: Ribonucleoproteins of Uukuniemi virus are circular. J Virol. 1975, 15 (2): 386-392.PubMed CentralPubMedGoogle Scholar
- Samso A, Bouloy M, Hannoun C: [Circular ribonucleoproteins in the virus Lumbo (Bunyavirus)]. C R Acad Sci Hebd Seances Acad Sci D. 1975, 280 (6): 779-782.PubMedGoogle Scholar
- Samso A, Bouloy M, Hannoun C: [Demonstration of circular ribonucleic acid in the Lumbo virus (Bunyavirus)]. C R Acad Sci Hebd Seances Acad Sci D. 1976, 282 (17): 1653-1655.PubMedGoogle Scholar
- Betenbaugh M, Yu M, Kuehl K, White J, Pennock D, Spik K, Schmaljohn C: Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus. Virus Res. 1995, 38 (2-3): 111-124. 10.1016/0168-1702(95)00053-S.View ArticlePubMedGoogle Scholar
- Jiang X, Wang M, Graham DY, Estes MK: Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol. 1992, 66 (11): 6527-6532.PubMed CentralPubMedGoogle Scholar
- Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT: Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A. 1992, 89 (24): 12180-12184. 10.1073/pnas.89.24.12180.PubMed CentralView ArticlePubMedGoogle Scholar
- Laurent S, Vautherot JF, Madelaine MF, Le Gall G, Rasschaert D: Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J Virol. 1994, 68 (10): 6794-6798.PubMed CentralPubMedGoogle Scholar
- Chen SY, Matsuoka Y, Compans RW: Golgi complex localization of the Punta Toro virus G2 protein requires its association with the G1 protein. Virology. 1991, 183 (1): 351-365. 10.1016/0042-6822(91)90148-5.View ArticlePubMedGoogle Scholar
- Melin L, Persson R, Andersson A, Bergstrom A, Ronnholm R, Pettersson RF: The membrane glycoprotein G1 of Uukuniemi virus contains a signal for localization to the Golgi complex. Virus Res. 1995, 36 (1): 49-66. 10.1016/0168-1702(95)00006-C.View ArticlePubMedGoogle Scholar
- Anderson GW, Smith JF: Immunoelectron microscopy of Rift Valley fever viral morphogenesis in primary rat hepatocytes. Virology. 1987, 161 (1): 91-100. 10.1016/0042-6822(87)90174-7.View ArticlePubMedGoogle Scholar
- Liu L, Lomonossoff G: A site-directed mutagenesis method utilising large double-stranded DNA templates for the simultaneous introduction of multiple changes and sequential multiple rounds of mutation: Application to the study of whole viral genomes. J Virol Methods. 2006, 137 (1): 63-71. 10.1016/j.jviromet.2006.05.034.View ArticlePubMedGoogle Scholar
- Livingstone C, Jones I: Baculovirus expression vectors with single strand capability. Nucleic Acids Res. 1989, 17 (6): 2366-10.1093/nar/17.6.2366.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhao Y, Chapman DA, Jones IM: Improving baculovirus recombination. Nucleic Acids Res. 2003, 31 (2): E6-6. 10.1093/nar/gng006.PubMed CentralView ArticlePubMedGoogle Scholar
- Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227 (5259): 680-685. 10.1038/227680a0.View ArticlePubMedGoogle Scholar
- Sambrook J, Russell DW: Molecular Cloning: A Laboratory Manual. 2001, Cold Spring Harbor, New York , Cold Spring Harbor Laboratory Press, ThirdGoogle Scholar
- Schmaljohn CS, Hasty SE, Harrison SA, Dalrymple JM: Characterization of Hantaan virions, the prototype virus of hemorrhagic fever with renal syndrome. J Infect Dis. 1983, 148 (6): 1005-1012.View ArticlePubMedGoogle Scholar
- Obijeski JF, Marchenko AT, Bishop DH, Cann BW, Murphy FA: Comparative electrophoretic analysis of the virus proteins of four rhabdoviruses. J Gen Virol. 1974, 22 (1): 21-33. 10.1099/0022-1317-22-1-21.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.